サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1618294

電子処方の世界市場の評価：製品別、デリバリー方式別、エンドユーザー別、地域別、機会、予測（2018年～2032年）

E-Prescribing Market Assessment, By Product [Solutions, Services], By Delivery Mode [Web/Cloud-Based, On-Premises], By End-user [Hospitals, Pharmacies, Office-Based Physicians], By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 244 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
電子処方の世界市場の評価：製品別、デリバリー方式別、エンドユーザー別、地域別、機会、予測（2018年～2032年）
出版日: 2024年12月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 244 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の電子処方の市場規模は、2024年の39億3,000万米ドルから2032年に239億5,000万米ドルに達すると予測され、予測期間の2025年～2032年にCAGRで25.35%の成長が見込まれます。市場は、デジタル医療ソリューションの採用が増加し、医療費の最小化に注目が集まっていることから、予測期間に力強い成長が見込まれます。

電子処方は、医師が正確で間違いがなく、理解しやすい処方箋を、診療時点から薬局に直接電子的に送信することを可能にし、患者ケアの質を向上における重要な要素となっています。市場成長の主な促進要因は、先進地域を中心とした電子カルテ（EHR）や電子処方システムを推進する政府の取り組みや、慢性疾患の有病率が増加し、医療従事者が効率的な処方管理システムを求めるようになっていることです。このようなコスト抑制効果に加え、医療ワークフローを合理化する必要性が高まっていることから、電子処方は医療提供者や組織にとって魅力的なソリューションとなっています。製品の発売と市場の拡大が市場の成長をさらに後押ししています。例えば2023年11月、AstraZeneca plcは、臨床試験と患者ケアを強化するため、デジタルヘルスソリューションプロバイダーであるEvinovaを立ち上げました。AstraZenecaの支援を受け、Parexel International（MA）CorporationおよびFortrea Inc.と協業しているEvinovaは、確立されたデジタル技術による医薬品開発の最適化に注力しており、遠隔患者モニタリングやデジタル治療への拡大を計画しています。

当レポートでは、世界の電子処方市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の電子処方市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品別
    • デリバリー方式別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析：企業別（金額）（上位5社とその他 - 2024年）
  • 市場マップ分析（2024年）
    • 製品別
    • デリバリー方式別
    • エンドユーザー別
    • 地域別

第5章 北米の電子処方市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品別
    • デリバリー方式別
    • エンドユーザー別
    • シェア：国別
  • 各国の市場の評価
    • 米国の電子処方市場の見通し（2018年～2032年）
    • カナダ
    • メキシコ

第6章 欧州の電子処方市場の見通し（2018年～2032年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • ポーランド

第7章 アジア太平洋の電子処方市場の見通し（2018年～2032年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • インドネシア
  • フィリピン

第8章 南米の電子処方市場の見通し（2018年～2032年）

  • ブラジル
  • アルゼンチン

第9章 中東・アフリカの電子処方市場の見通し（2018年～2032年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • イスラエル

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

  • 市場促進要因
  • 市場の課題

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

  • 規制当局の承認
  • イノベーション

第18章 特許情勢

第19章 ケーススタディ

第20章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • Practice Fusion, Inc.
    • McKesson Corporation
    • Networking Technology, Inc. dba RXNT
    • Athenahealth, Inc.
    • EMDs, Inc. (CopuGroup Medical, Inc.)
    • Cerner Corporation
    • UnitedHealth Group
    • Epic Systems Corporation
    • NextGen Healthcare, Inc.
    • DrFirst.com, Inc.

第21章 戦略的推奨

第22章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 3. Global E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 4. Global E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global E-Prescribing Market Share (%), By Region, 2018-2032F
  • Figure 6. North America E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 8. North America E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 9. North America E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 11. United States E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 13. United States E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 14. United States E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 17. Canada E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 18. Canada E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 21. Mexico E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 22. Mexico E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 25. Europe E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 26. Europe E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 30. Germany E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 31. Germany E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 32. France E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 34. France E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 35. France E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 38. Italy E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 39. Italy E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 42. United Kingdom E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 43. United Kingdom E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 46. Russia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 47. Russia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 50. Netherlands E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 51. Netherlands E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 54. Spain E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 55. Spain E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 58. Turkey E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 59. Turkey E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 62. Poland E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 63. Poland E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 66. South America E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 67. South America E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 71. Brazil E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 72. Brazil E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 75. Argentina E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 76. Argentina E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 79. Asia-Pacific E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 80. Asia-Pacific E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 82. India E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 84. India E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 85. India E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 86. China E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 88. China E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 89. China E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 92. Japan E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 93. Japan E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 96. Australia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 97. Australia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 100. Vietnam E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 101. Vietnam E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 104. South Korea E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 105. South Korea E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 108. Indonesia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 109. Indonesia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 112. Philippines E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 113. Philippines E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 116. Middle East & Africa E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 117. Middle East & Africa E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 121. Saudi Arabia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 122. Saudi Arabia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 125. UAE E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 126. UAE E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 129. South Africa E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 130. South Africa E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Delivery Mode Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX12444

Global e-prescribing market is projected to witness a CAGR of 25.35% during the forecast period 2025-2032, growing from USD 3.93 billion in 2024 to USD 23.95 billion in 2032. The global e-prescribing market is expected to grow robustly during the forecast period owing to the increasing adoption of digital healthcare solutions and the rising focus on minimizing healthcare costs.

E-prescribing enables physicians to transmit accurate, error-free, and easy-to-understand prescriptions electronically from the point of care directly to pharmacies and is a key element in improving the quality of patient care. Key factors driving the market growth include government initiatives promoting electronic health records (EHR) and e-prescribing systems, especially in developed regions, and the increasing prevalence of chronic diseases, which are pushing healthcare providers towards efficient prescription management systems. These cost-containment benefits, along with the growing need to streamline healthcare workflow, have made e-prescribing an attractive solution for healthcare providers and organizations. Product launch and market expansion further fuel the market growth. For instance, in November 2023, AstraZeneca plc launched Evinova, a digital health solutions provider, to enhance clinical trials and patient care. Backed by AstraZeneca and in collaboration with Parexel International (MA) Corporation and Fortrea Inc., Evinova focuses on optimizing drug development through established digital technologies, with plans to expand into remote patient monitoring and digital therapeutics.

Increased Focus on Cost Reduction Boosts Market Growth

Increasing focus on cost reduction for healthcare is a growth driver for the e-prescription market as healthcare organizations continue to look for ways to streamline operations and reduce financial burden while still providing quality patient care. E-prescription systems significantly reduce costs by minimizing the time and resources required to manage prescriptions, thus reducing administrative costs. In addition, e-prescription contributes to more efficient inventory management as a medical service provider can avoid unnecessary drug waste, further reducing operating costs. Fuel the market growth. For instance, in July 2024, Commure, Inc. acquired Augmedix, Inc., for USD 139 million to enhance AI-driven clinical documentation and revenue cycle automation. Augmedix, Inc., will become a subsidiary of Commure, Inc., allowing the companies to scale their solutions and improve clinician productivity across health systems. The combined technologies aim to support over three million physician appointments this year.

Technological Advancements in Healthcare-IT and Digital Health

Technological advancements in the healthcare IT and digital health sectors are primarily driving the growth of the e-prescription market. Advanced technologies with cloud platforms, artificial intelligence, and machine learning have substantially enhanced the capabilities and efficiency of systems for e-prescribing. These innovations make prescribing easier and allow live access to and management of prescription information from nearly anywhere. In addition, cloud-based e-prescribing solutions offer a cost-effective, easy-to-deploy platform, even for smaller practices, while AI and machine learning enable more advanced capabilities, such as predictive analytics on patient medication adherence and drug interaction alerts. For instance, in December 2023, DrFirst.com, Inc. launched iPrescribe Connect, a new feature that enhances communication for prescribers while maintaining privacy. This tool allows prescribers to contact patients using their personal mobile phones without revealing personal information, displaying a customizable office number instead. iPrescribe Connect, included with every paid subscription, uses caller ID masking technology to improve patient recognition and response rates, offering flexibility for prescribers to work on the go.

Web/Cloud-Based Segment to Dominate the E-Prescribing Market

The web/cloud-based segment is expected to dominate the e-prescribing market, primarily due to its high-cost efficiency, scalability, and flexibility in deployment. Cloud-based e-prescribing systems do not require high investments in IT infrastructure and hardware. This attracts healthcare facilities of all sizes, especially smaller clinics and independent practices. Healthcare providers can access prescription data securely from anywhere, which enhances the possibility of remote care and real-time decision-making. Integrating electronic health records and other healthcare applications is also easier with cloud-based platforms. The web/cloud-based segment is expected to lead the market as the healthcare industry's attention shifts towards digital, flexible, and cost-effective solutions. For instance, in March 2022, First Databank, Inc. launched FDB Vela, a cloud-native ePrescribing network designed to streamline the flow of medication information, benefits verification, and clinical decision support among prescribers, payers, pharmacies, and other stakeholders. The platform provides non-exclusive transaction services, helping participants enhance value for their customers and patients through improved prescribing and fulfillment processes.

North America Dominates the E-Prescribing Market

North America is likely to be one of the prominent regions in the global market for e-prescribing, led primarily by its well-developed infrastructure in healthcare, high adoption rates of advanced healthcare IT solutions, and a supportive regulatory environment. Such widespread adoption of e-prescribing systems through the high priority laid by the region in reducing medication errors and improving patient safety in the United States, especially, has been accelerated through federal mandates and incentives under programs like the Health Information Technology for Economic and Clinical Health (HITECH) Act. For instance, in October 2024, Tarrant Capital IP, LLC acquired a majority stake in Surescripts, LLC to drive further investment in its e-prescribing technology and explore M&A opportunities. The deal strengthens Surescripts, LLC's position as a leader in electronic healthcare transactions, connecting over 2 million healthcare professionals and covering 99% of the United States population.

Future Market Scenario (2024-2031F)

The global e-prescribing market is expected to seem very promising in the forecast period, as it is being driven by continuous and progressive healthcare technology advancements, increased demand for efficient and error-free medication management, and ever-growing adoption in both developed and emerging markets. E-prescribing systems will probably remain a key element of the digital health strategy for healthcare providers worldwide to focus on quality and efficiency in patient care. Improved integration with AI and machine learning might increase functionalities involving predictive analytics related to patient adherence, personalized advice on medication, and improved alert systems regarding interactions of drugs. Market expansion is expected to increase with more emerging cloud-based e-prescribing solutions. These focus on cost-effective, scalable platforms easily deployed in various healthcare settings.

For instance, in July 2024, Canada Health Infoway Inc. and Ava Industries Inc. partnered to integrate PrescribeIT, Canada's national e-prescribing service, into Ava Industries Inc.'s electronic medical record (EMR) system, benefiting over 1,000 prescribers. This integration will enable healthcare providers to send prescriptions directly to pharmacies, enhancing efficiency and patient outcomes. Ava's AI-driven tools and streamlined processes, combined with PrescribeIT, align to reduce administrative burdens and improve digital healthcare workflows. This collaboration advances both organizations' missions to enhance medication management and improve patient care.

Key Players Landscape and Outlook

The market for e-prescribing is segmented into products and services that are intended to increase the accuracy, efficiency, and accessibility of prescription management. In the service segment, the market is highly fragmented, with a huge number of local and global service providers offering comprehensive solutions. The new developments in e-prescribing in the market include the new product features and services that have been launched. As well as business strategic agreements involving mergers, acquisitions, and partnerships that help expand the market and enhance service integration.

For instance, the first electronic prescription service in Wales, England, was launched in the town of Rhyl, allowing general practitioners to send prescriptions securely to pharmacies and eliminating paper forms. This service improves efficiency, reduces environmental impact, and simplifies the prescription process. It is currently in live testing, with a full rollout across Wales that happened in January 2024.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global E-Prescribing Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Solutions
        • 4.2.1.1.1. Integrated Solutions
        • 4.2.1.1.2. Standalone Solutions
      • 4.2.1.2. Services
        • 4.2.1.2.1. Support
        • 4.2.1.2.2. Implementation
        • 4.2.1.2.3. Training
        • 4.2.1.2.4. Networks
    • 4.2.2. By Delivery Mode
      • 4.2.2.1. Web/Cloud-Based
      • 4.2.2.2. On-premises
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Pharmacies
      • 4.2.3.3. Office-Based Physicians
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product
    • 4.3.2. By Delivery Mode
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America E-Prescribing Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Solutions
        • 5.2.1.1.1. Integrated Solutions
        • 5.2.1.1.2. Standalone Solutions
      • 5.2.1.2. Services
        • 5.2.1.2.1. Support
        • 5.2.1.2.2. Implementation
        • 5.2.1.2.3. Training
        • 5.2.1.2.4. Networks
    • 5.2.2. By Delivery Mode
      • 5.2.2.1. Web/Cloud-Based
      • 5.2.2.2. On-Premises
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Pharmacies
      • 5.2.3.3. Office-Based Physicians
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States E-Prescribing Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Solutions
          • 5.3.1.2.1.1.1. Integrated Solutions
          • 5.3.1.2.1.1.2. Standalone Solutions
          • 5.3.1.2.1.2. Services
          • 5.3.1.2.1.2.1. Support
          • 5.3.1.2.1.2.2. Implementation
          • 5.3.1.2.1.2.3. Training
          • 5.3.1.2.1.2.4. Networks
        • 5.3.1.2.2. By Delivery Mode
          • 5.3.1.2.2.1. Web/Cloud-Based
          • 5.3.1.2.2.2. On-premises
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Hospitals
          • 5.3.1.2.3.2. Pharmacies
          • 5.3.1.2.3.3. Office-Based Physicians
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe E-Prescribing Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific E-Prescribing Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. Indonesia
  • 7.7. Philippines

8. South America E-Prescribing Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa E-Prescribing Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Regulatory Approvals
  • 17.2. Innovations

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Practice Fusion, Inc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. McKesson Corporation
    • 20.3.3. Networking Technology, Inc. dba RXNT
    • 20.3.4. Athenahealth, Inc.
    • 20.3.5. EMDs, Inc. (CopuGroup Medical, Inc.)
    • 20.3.6. Cerner Corporation
    • 20.3.7. UnitedHealth Group
    • 20.3.8. Epic Systems Corporation
    • 20.3.9. NextGen Healthcare, Inc.
    • 20.3.10. DrFirst.com, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer